标普和纳斯达克内在价值 联系我们

China SXT Pharmaceuticals, Inc. SXTC NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • CN • USD

SharesGrow Score
28/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

China SXT Pharmaceuticals, Inc. (SXTC) 是一家上市公司 属于 医疗保健 板块,经营于 制药 - 专科与仿制药 行业. 公司总部位于 Taizhou, 中国. 现任CEO为 Feng Zhou.

SXTC 拥有 IPO日期为 2019-01-04, 75 名全职员工, 在 NASDAQ Capital Marke, 市值为 $1.59M.

关于 China SXT Pharmaceuticals, Inc.

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

📍 178 Taidong Road North, Taizhou 225300 📞 86 523 8629 8290
公司详情
所属板块医疗保健
细分行业制药 - 专科与仿制药
国家中国
交易所NASDAQ Capital Marke
货币USD
IPO日期2019-01-04
首席执行官Feng Zhou
员工数75
交易信息
当前价格$1.86
市值$1.59M
52周区间1.25-1047
Beta1.75
ETF
ADR
CUSIPG2161P165
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言